AnaptysBio Announces Portfolio Update Across Best-in-Class Immune Cell Modulating Antibodies

Go back to AnaptysBio Announces Portfolio Update Across Best-in-Class Immune Cell Modulating Antibodies
(NASDAQ: ANAB) Delayed: 55.16 --0 (-0%)
Previous Close $55.16    52 Week High
Open $55.16    52 Week Low
Day High $55.16    P/E N/A 
Day Low $55.16    EPS
Volume 103